Medarex, Inc
Article Abstract:
The shares of Medarex Inc. have good price appreciation potential over the 2010-2012 timeframe. The Princeton, New Jersey-based company is engaged in the development of pharmaceutical products using its patented human monoclonal antibody production technology.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Evaluation, Stocks, Stock prices
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Medarex Inc
Article Abstract:
A comparative analysis of the company sales and earnings and the financial details of Medarex Inc. from 1994 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
United States, Sales, profits & dividends, Company sales and earnings, Company earnings/profit
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Biological products industry, Securities, Company securities, Medarex Inc., MEDX
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.